Literature DB >> 33538798

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.

Vivien Kohlhaas1,2,3,4,5, Stuart James Blakemore3,4,6, Mona Al-Maarri1,2,3,4,5, Nadine Nickel3,4,6, Martin Pal1,2,3,4,5, Andreas Roth3,4,6, Nadine Hövelmeyer7, Stephan C Schäfer8, Gero Knittel3,4,6, Philipp Lohneis8, Milos Nikolic4,9, Janica L Wiederstein3,9, Marek Franitza10, Theodoros Georgomonolis10,11, Nina Reinart3,4,6, Marco Herling3,4,6, Carmen Herling3,4,6, Elena M Hartmann12, Andreas Rosenwald12, Wolfram Klapper13, Reinhard Büttner8, Riccardo Moia14, Davide Rossi15,16, Renzo Boldorini14,17, Gianluca Gaidano17, Lukas P Frenzel3,4,6, Hans Christian Reinhardt3,4,6,18, Jens C Brüning1,2,3,4,5, Michael Hallek3,4,6, Marcus Krüger3,9, Martin Peifer4,9, Christian P Pallasch3,4,6, F Thomas Wunderlich1,2,3,4,5.   

Abstract

Richter's transformation (RT) is an aggressive lymphoma that occurs upon progression from chronic lymphocytic leukemia (CLL). Transformation has been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1; however, a significant proportion of RT cases lack CLL phase-associated events. Here, we report that high levels of AKT phosphorylation occur both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1 CLL mouse model resulted in CLL transformation to RT with significantly reduced survival and an aggressive lymphoma phenotype. In the absence of recurrent mutations, we identified a profile of genomic aberrations intermediate between CLL and diffuse large B-cell lymphoma. Multiomics assessment by phosphoproteomic/proteomic and single-cell transcriptomic profiles of this Akt-induced murine RT revealed an S100 protein-defined subcluster of highly aggressive lymphoma cells that developed from CLL cells, through activation of Notch via Notch ligand expressed by T cells. Constitutively active Notch1 similarly induced RT of murine CLL. We identify Akt activation as an initiator of CLL transformation toward aggressive lymphoma by inducing Notch signaling between RT cells and microenvironmental T cells.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33538798     DOI: 10.1182/blood.2020005734

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies.

Authors:  Vivek Kumar; Mohit Vashishta; Lin Kong; Xiaodong Wu; Jiade J Lu; Chandan Guha; B S Dwarakanath
Journal:  Front Cell Dev Biol       Date:  2021-04-22

2.  AKT: a key to RT?

Authors:  Jennifer R Brown
Journal:  Blood       Date:  2021-02-04       Impact factor: 25.476

Review 3.  The Role of RhoH in TCR Signalling and Its Involvement in Diseases.

Authors:  Ana Masara Ahmad Mokhtar; Ilie Fadzilah Hashim; Muaz Mohd Zaini Makhtar; Nor Hawani Salikin; Syafinaz Amin-Nordin
Journal:  Cells       Date:  2021-04-20       Impact factor: 6.600

Review 4.  Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective.

Authors:  Marwan Kwok; Catherine J Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

Review 5.  O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.

Authors:  David E Spaner
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

Review 6.  Novel Approaches for the Treatment of Patients with Richter's Syndrome.

Authors:  Andrea Iannello; Silvia Deaglio; Tiziana Vaisitti
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

7.  CARD9 Forms an Alternative CBM Complex in Richter Syndrome.

Authors:  Julia Maier; André Lechel; Ralf Marienfeld; Thomas F E Barth; Peter Möller; Kevin Mellert
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 8.  Targeting Bruton's Tyrosine Kinase in CLL.

Authors:  Inhye E Ahn; Jennifer R Brown
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

Review 9.  Notch signaling pathway: architecture, disease, and therapeutics.

Authors:  Binghan Zhou; Wanling Lin; Yaling Long; Yunkai Yang; Huan Zhang; Kongming Wu; Qian Chu
Journal:  Signal Transduct Target Ther       Date:  2022-03-24

10.  CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.

Authors:  Ulrich Keller; Stefan Habringer; Richard Lewis; H Carlo Maurer; Nikita Singh; Irene Gonzalez-Menendez; Matthias Wirth; Markus Schick; Le Zhang; Konstandina Isaakidis; Anna Katharina Scherger; Veronika Schulze; Junyan Lu; Thorsten Zenz; Katja Steiger; Roland Rad; Leticia Quintanilla-Martinez; Marion Espeli; Karl Balabanian
Journal:  Leukemia       Date:  2021-08-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.